Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs), which regulate gene expression by partial complementarity to the 3' untranslated region of their target genes, have been implicated in cancer initiation and progression. However, the molecular mechanism underlying the regulation of miRNA expression during pancreatic tumorigenesis has not been extensively reported. In this study, we first compared the miRNA expression in human pancreatic cancers and adjacent normal tissues by miRNA array and identified 12 differentially expressed miRNAs. miR-132, which is downregulated in tumors, was further studied in greater detail. Decreased expression of miR-132 was confirmed in 16 of 20 pancreatic carcinomas (P < 0.0001), compared with their respective benign tissues by TaqMan miRNA assays. miR-132 expression was remarkably influenced by promoter methylation in PANC1 and SW1990 cells. Promoter hypermethylation was observed in tumor samples but not in the normal counterparts, and the expression of miR-132 negatively correlated with its methylation status (P = 0.013). miR-132 was transcribed by RNA polymerase II, and Sp1 played a major role in miR-132 transcription. The expression of Sp1 correlated with that of miR-132 in tissues. Moreover, cancerous tissues showed significantly lower Sp1-binding affinity to the miR-132 promoter, relative to non-tumor samples. Proliferation and colony formation of pancreatic cancer cells were suppressed in cells transfected with miR-132 mimics and enhanced in cells transfected with miR-132 inhibitor by negatively regulating the Akt-signaling pathway. Our present findings illustrate the mechanism driving miR-132 downregulation and the important role of miR-132 in pancreatic cancer development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,750
MicroRNA biogenesis: coordinated cropping and dicing
Kim, V. N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1644 · Cited by 2,546
MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000610 · Cited by 754
Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., Scheppke, L., Huang, M., Shields, D. J., Lindquist, J. N., Lapinski, P. E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2186 · Cited by 517
Research works printed but not linked: 32
- Guo, 2005, Current diagnosis and treatment of pancreatic cancer in China, Pancreas, 31, 13, 10.1097/01.mpa.0000168220.97967.d1 · DOI
- Pliarchopoulou, 2009, Pancreatic cancer: current and future treatment strategies, Cancer Treat. Rev., 35, 431, 10.1016/j.ctrv.2009.02.005 · DOI
- Sato, 2006, The role of epigenetic alterations in pancreatic cancer, J. Hepatobiliary Pancreat. Surg., 13, 286, 10.1007/s00534-005-1057-1 · DOI
- Jones, 2008, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, 321, 1801, 10.1126/science.1164368 · DOI · Paper page
- Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
- Zhang, 2007, MicroRNAs and their regulatory roles in animals and plants, J. Cell. Physiol., 210, 279, 10.1002/jcp.20869 · DOI · Paper page
- Cai, 2009, A brief review on the mechanisms of miRNA regulation, Genomics Proteomics Bioinformatics, 7, 147, 10.1016/S1672-0229(08)60044-3 · DOI · Paper page
- Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat. Rev. Genet., 10, 704, 10.1038/nrg2634 · DOI · Paper page
- Rachagani, 2010, MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications, Cancer Lett., 292, 8, 10.1016/j.canlet.2009.11.010 · DOI
- Grunau, 2001, Bisulfite genomic sequencing: systematic investigation of critical experimental parameters, Nucleic Acids Res., 29, EE65, 10.1093/nar/29.13.e65 · DOI · Paper page
- Bloomston, 2007, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis, JAMA, 297, 1901, 10.1001/jama.297.17.1901 · DOI · Paper page
- Zhang, 2009, Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis, World J. Surg., 33, 698, 10.1007/s00268-008-9833-0 · DOI · Paper page
- Lee, 2007, Expression profiling identifies microRNA signature in pancreatic cancer, Int. J. Cancer., 120, 1046, 10.1002/ijc.22394 · DOI · Paper page
- Yan, 2008, MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis, RNA, 14, 2348, 10.1261/rna.1034808 · DOI · Paper page
- Du, 2009, Down-regulation of miR-141 in gastric cancer and its involvement in cell growth, J. Gastroenterol., 44, 556, 10.1007/s00535-009-0037-7 · DOI · Paper page
- Porkka, 2007, MicroRNA expression profiling in prostate cancer, Cancer Res., 67, 6130, 10.1158/0008-5472.CAN-07-0533 · DOI · Paper page
- Bandres, 2006, Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues, Mol. Cancer., 5, 29, 10.1186/1476-4598-5-29 · DOI
- Magill, 2010, microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus, Proc. Natl Acad. Sci. USA., 107, 20382, 10.1073/pnas.1015691107 · DOI · Paper page
- Vo, 2005, A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis, Proc. Natl Acad. Sci. USA., 102, 16426, 10.1073/pnas.0508448102 · DOI · Paper page
- Lee, 2002, MicroRNA maturation: stepwise processing and subcellular localization, EMBO J., 21, 4663, 10.1093/emboj/cdf476 · DOI · Paper page
- Smalheiser, 2003, EST analyses predict the existence of a population of chimeric microRNA precursor-mRNA transcripts expressed in normal human and mouse tissues, Genome Biol., 4, 403, 10.1186/gb-2003-4-7-403 · DOI
- Cullen, 2004, Transcription and processing of human microRNA precursors, Mol. Cell., 16, 861, 10.1016/j.molcel.2004.12.002 · DOI · Paper page
- Lee, 2004, MicroRNA genes are transcribed by RNA polymerase II, EMBO J., 23, 4051, 10.1038/sj.emboj.7600385 · DOI · Paper page
- Borchert, 2006, RNA polymerase III transcribes human microRNAs, Nat. Struct. Mol. Biol., 13, 1097, 10.1038/nsmb1167 · DOI · Paper page
- Lagos, 2010, miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator, Nat. Cell Biol., 12, 513, 10.1038/ncb2054 · DOI · Paper page
- Won, 2002, Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells, FASEB J., 16, 1943, 10.1096/fj.02-0311fje · DOI · Paper page
- Esteve, 2007, Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells, J. Biol. Chem., 282, 2615, 10.1074/jbc.M606203200 · DOI · Paper page
- Osada, 2000, Critical role of extracellular signal-regulated kinase (ERK) phosphorylation in novel vitamin K analog-induced cell death, Jpn. J. Cancer Res., 91, 1250, 10.1111/j.1349-7006.2000.tb00911.x · doi:10.1111/j.1349-7006.2000.tb00911.x
- Schlieman, 2003, Incidence, mechanism and prognostic value of activated AKT in pancreas cancer, Br. J. Cancer., 89, 2110, 10.1038/sj.bjc.6601396 · DOI · Paper page
- Yamamoto, 2004, Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma, Clin. Cancer Res., 10, 2846, 10.1158/1078-0432.CCR-02-1441 · DOI · Paper page
- Yoshida, 2004, Development of gene therapy to target pancreatic cancer, Cancer Sci., 95, 283, 10.1111/j.1349-7006.2004.tb03204.x · DOI
- Biliran, 2005, Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line, Clin. Cancer Res., 11, 6075, 10.1158/1078-0432.CCR-04-2419 · DOI · Paper page
Cited by
miR-212/132 expression and functions: within and beyond the neuronal compartment
Wanet, A., Tacheny, A., Arnould, T., & Renard, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks151 · Cited by 330
MicroRNA-132 enhances transition from inflammation to proliferation during wound healing
Li, D., Wang, A., Liu, X., Meisgen, F., Grünler, J., Botusan, I. R., Narayanan, S., Erikci, E., Li, X., Blomqvist, L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79052 · Cited by 231
Li, J., Wu, H., Li, W., Yin, L., Guo, S., Xu, X., Ouyang, Y., Zhao, Z., Liu, S., Tian, Y., et al. (2016) · Oncogene · doi:10.1038/onc.2016.90 · Cited by 167
MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways
El Fatimy, R., Li, S., Chen, Z., Mushannen, T., Gongala, S., Wei, Z., Balu, D. T., Rabinovsky, R., Cantlon, A., Elkhal, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1880-5 · Cited by 161
Tang, Y., Cui, Y., Li, Z., Jiao, Z., Zhang, Y., He, Y., Chen, G., Zhou, Q., Wang, W., Zhou, X., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0285-3 · Cited by 152
Self-citation
Metadata
- Authors
- Zhang, S., Hao, J., Xie, F., Hu, X., Liu, C., Tong, J., Zhou, J., Wu, J., & Shao, C.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-10
- Volume
- 32
- Issue
- 8
- Pages
- 1183-1189
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2154086676
- Cited by
- 148
- References
- 5
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.